Editors   FDA: Possibly First Ever Stem Cell Drug for FDA Approval   1/17/2009 11:31:00 AM    
Osiris Therapeutics (NASDAQ:OSIR) expects to have the first ever stem cell drug for FDA approval.

Prochymal would treat Graft vs. host disease, assisting bone marrow transplant patients to prevent the implanted marrow's immune cells from attacking the body.